Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep 1;85(9):1317–1321. doi: 10.1054/bjoc.2001.2094

Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma

W Ye 1, W-H Chow 2, J Lagergren 1, P Boffetta 1,4, G Boman 3, H-O Adami 1,5, O Nyrén 1
PMCID: PMC2375235  PMID: 11720467

Abstract

In the first cohort study of the question we followed 92 986 (42 663 men and 50 323 women) adult patients hospitalized for asthma in Sweden from 1965 to 1994 for an average of 8.5 years to evaluate their risk of oesophageal and gastric cardia adenocarcinoma. Standardized incidence ratio (SIR) adjusted for gender, age and calendar year was used to estimate relative risk, using the Swedish nationwide cancer incidence rates as reference. Asthmatic patients overall had a moderately elevated risk for oesophageal adenocarcinoma (SIR = 1.5, 95% confidence interval CI, 0.9–2.5) and gastric cardia cancer (SIR = 1.4, 95% CI, 1.0–1.9). However, the excess risks were largely confined to asthmatic patients who also had a discharge record of gastro-oesophageal reflux (SIR = 7.5, 95% CI, 1.6–22.0 and SIR = 7.1, 95% CI, 3.1–14.0, respectively). No significant excess risk for oesophageal squamous-cell carcinoma or distal stomach cancer was observed. In conclusion, asthma is associated with a moderately elevated risk of developing oesophageal or gastric cardia adenocarcinoma. Special clinical vigilance vis-à-vis gastro-esophageal cancers seems unwarranted in asthmatic patients, but may be appropriate in those with clinically manifest gastro-oesophageal reflux.   http://www.bjcancer.com © 2001 Cancer Research Campaign

Keywords: asthma, gastro-oesophageal reflux, adenocarcinoma of the oesophagus and gastric cardia

Full Text

The Full Text of this article is available as a PDF (56.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Camargo C. A., Jr, Weiss S. T., Zhang S., Willett W. C., Speizer F. E. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med. 1999 Nov 22;159(21):2582–2588. doi: 10.1001/archinte.159.21.2582. [DOI] [PubMed] [Google Scholar]
  2. Chow W. H., Blot W. J., Vaughan T. L., Risch H. A., Gammon M. D., Stanford J. L., Dubrow R., Schoenberg J. B., Mayne S. T., Farrow D. C. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998 Jan 21;90(2):150–155. doi: 10.1093/jnci/90.2.150. [DOI] [PubMed] [Google Scholar]
  3. Chow W. H., Finkle W. D., McLaughlin J. K., Frankl H., Ziel H. K., Fraumeni J. F., Jr The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA. 1995 Aug 9;274(6):474–477. [PubMed] [Google Scholar]
  4. Devesa S. S., Blot W. J., Fraumeni J. F., Jr Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998 Nov 15;83(10):2049–2053. [PubMed] [Google Scholar]
  5. Farrow D. C., Vaughan T. L., Sweeney C., Gammon M. D., Chow W. H., Risch H. A., Stanford J. L., Hansten P. D., Mayne S. T., Schoenberg J. B. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control. 2000 Mar;11(3):231–238. doi: 10.1023/a:1008913828105. [DOI] [PubMed] [Google Scholar]
  6. Field S. K., Gelfand G. A., McFadden S. D. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest. 1999 Sep;116(3):766–774. doi: 10.1378/chest.116.3.766. [DOI] [PubMed] [Google Scholar]
  7. Field S. K., Sutherland L. R. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature. Chest. 1998 Jul;114(1):275–283. doi: 10.1378/chest.114.1.275. [DOI] [PubMed] [Google Scholar]
  8. Field S. K., Underwood M., Brant R., Cowie R. L. Prevalence of gastroesophageal reflux symptoms in asthma. Chest. 1996 Feb;109(2):316–322. doi: 10.1378/chest.109.2.316. [DOI] [PubMed] [Google Scholar]
  9. Floreani A. A., Rennard S. I. The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms. Curr Opin Pulm Med. 1999 Jan;5(1):38–46. doi: 10.1097/00063198-199901000-00007. [DOI] [PubMed] [Google Scholar]
  10. Gammon M. D., Schoenberg J. B., Ahsan H., Risch H. A., Vaughan T. L., Chow W. H., Rotterdam H., West A. B., Dubrow R., Stanford J. L. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997 Sep 3;89(17):1277–1284. doi: 10.1093/jnci/89.17.1277. [DOI] [PubMed] [Google Scholar]
  11. Hansson L. E., Sparén P., Nyrén O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer. 1993 May 28;54(3):402–407. doi: 10.1002/ijc.2910540309. [DOI] [PubMed] [Google Scholar]
  12. Harding S. M., Guzzo M. R., Richter J. E. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest. 1999 Mar;115(3):654–659. doi: 10.1378/chest.115.3.654. [DOI] [PubMed] [Google Scholar]
  13. Irwin R. S., Curley F. J., French C. L. Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol. Chest. 1993 Jun;103(6):1662–1669. doi: 10.1378/chest.103.6.1662. [DOI] [PubMed] [Google Scholar]
  14. Kjellén G., Brundin A., Tibbling L., Wranne B. Oesophageal function in asthmatics. Eur J Respir Dis. 1981;62(2):87–94. [PubMed] [Google Scholar]
  15. Lagergren J., Bergström R., Adami H. O., Nyrén O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000 Aug 1;133(3):165–175. doi: 10.7326/0003-4819-133-3-200008010-00007. [DOI] [PubMed] [Google Scholar]
  16. Lagergren J., Bergström R., Lindgren A., Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999 Mar 18;340(11):825–831. doi: 10.1056/NEJM199903183401101. [DOI] [PubMed] [Google Scholar]
  17. Lagergren J., Bergström R., Lindgren A., Nyrén O. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer. 2000 Feb 1;85(3):340–346. [PubMed] [Google Scholar]
  18. Lagergren J., Bergström R., Nyrén O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999 Jun 1;130(11):883–890. doi: 10.7326/0003-4819-130-11-199906010-00003. [DOI] [PubMed] [Google Scholar]
  19. Lundbäck B., Stjernberg N., Nyström L., Lundbäck K., Lindström M., Rosenhall L. An interview study to estimate prevalence of asthma and chronic bronchitis. The obstructive lung disease in northern Sweden study. Eur J Epidemiol. 1993 Mar;9(2):123–133. doi: 10.1007/BF00158781. [DOI] [PubMed] [Google Scholar]
  20. Mattsson B., Rutqvist L. E., Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol. 1985 Mar;14(1):64–69. doi: 10.1093/ije/14.1.64. [DOI] [PubMed] [Google Scholar]
  21. Montnémery P., Adelroth E., Heuman K., Johannisson A., Johansson S. A., Lindholm L. H., Lundbäck B., Löfdahl C. G. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med. 1998 Dec;92(12):1337–1345. doi: 10.1016/s0954-6111(98)90139-1. [DOI] [PubMed] [Google Scholar]
  22. Nyrén O., McLaughlin J. K., Gridley G., Ekbom A., Johnell O., Fraumeni J. F., Jr, Adami H. O. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst. 1995 Jan 4;87(1):28–33. doi: 10.1093/jnci/87.1.28. [DOI] [PubMed] [Google Scholar]
  23. Sears M. R. Descriptive epidemiology of asthma. Lancet. 1997 Oct;350 (Suppl 2):SII1–SII4. doi: 10.1016/s0140-6736(97)90028-3. [DOI] [PubMed] [Google Scholar]
  24. Sontag S. J., O'Connell S., Khandelwal S., Miller T., Nemchausky B., Schnell T. G., Serlovsky R. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology. 1990 Sep;99(3):613–620. doi: 10.1016/0016-5085(90)90945-w. [DOI] [PubMed] [Google Scholar]
  25. Sontag S. J., Schnell T. G., Miller T. Q., Khandelwal S., O'Connell S., Chejfec G., Greenlee H., Seidel U. J., Brand L. Prevalence of oesophagitis in asthmatics. Gut. 1992 Jul;33(7):872–876. doi: 10.1136/gut.33.7.872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Vaughan T. L., Farrow D. C., Hansten P. D., Chow W. H., Gammon M. D., Risch H. A., Stanford J. L., Schoenberg J. B., Mayne S. T., Rotterdam H. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):749–756. [PubMed] [Google Scholar]
  27. Vincent D., Cohen-Jonathan A. M., Leport J., Merrouche M., Geronimi A., Pradalier A., Soulé J. C. Gastro-oesophageal reflux prevalence and relationship with bronchial reactivity in asthma. Eur Respir J. 1997 Oct;10(10):2255–2259. doi: 10.1183/09031936.97.10102255. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES